XFCH yields 2000000.00% · PFE yields 6.13%● Live data
📍 XFCH pulled ahead of the other in Year 1
Combined, XFCH + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of XFCH + PFE for your $10,000?
X-Factor Communications Holdings, Inc. provides interactive digital media network software and services in the United States. The company's flagship application include Digital Screen Control Portal, an interactive real-time digital media communications and broadcast platform that delivers single point publishing of emergency mass notifications, alerts, and rich informational content to various IP endpoint/device. Its solutions also comprise Corporate Communications Control Center, a platform for multi-media, multi-channel, and multi-dimensional internal and external corporate communications; and Marketing and Advertising Control Center for digital media network owners. In addition, the company's products consist of enterprise desktop, storefront and DMAX, multimedia player, and interactive kiosks services. Further, it offers various services consisting of creative services; a suite of professional grade digital media services, including digital media application development, live event production, content creation and management; and digital media Webcasting services that deliver compelling digital media content supporting corporate communications, marketing events, e-commerce, and information distribution services. The company serves healthcare, education, enterprise, transportation, advertising, real estate, retails, public venue, banking and financial, and other sectors. The company was formerly known as Organic Spice Imports, Inc. and changed its name to X-Factor Communications Holdings, Inc. in May 2012. The company was founded in 2005 and is based in Lyndhurst, New Jersey.
Full XFCH Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.